The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Metal Ions and Intrinsically Disordered Proteins and Peptides: From Cu/Zn Amyloid-β to General Principles
Abstract
The interaction of d-block metal ions (Cu, Zn, Fe, etc.) with intrinsically disordered proteins (IDPs) has gained interest, partly due to their proposed roles in several diseases, mainly neurodegenerative. A prominent member of IDPs is the peptide amyloid-β (Aβ) that aggregates into metal-enriched amyloid plaques, a hallmark of Alzheimer's disease, in which Cu and Zn are bound to Aβ. IDPs are a class of proteins and peptides that lack a unique 3D structure when the protein is isolated. This disordered structure impacts their interaction with metal ions compared with structured metalloproteins. Metalloproteins either have a preorganized metal binding site or fold upon metal binding, resulting in defined 3D structure with a well-defined metal site. In contrast, for Aβ and likely most of the other IDPs, the affinity for Cu(I/II) and Zn(II) is weaker and the interaction is flexible with different coordination sites present. Coordination of Cu(I/II) with Aβ is very dynamic including fast Cu-exchange reactions (milliseconds or less) that are intrapeptidic between different sites as well as interpeptidic. This highly dynamic metal-IDP interaction has a strong impact on reactivity and potential biological role: (i) Due to the low affinity compared with classical metalloproteins, IDPs likely bind metals only at special places or under special conditions. For Aβ, this is likely in the neurons that expel Zn or Cu into the synapse and upon metal dysregulation occurring in Alzheimer's disease. (ii) Amino acid substitutions (mutations) on noncoordinating residues can change drastically the coordination sphere. (iii) Considering the Cu/Zn-Aβ aberrant interaction, therapeutic strategies can be based on removal of Cu/Zn or precluding their binding to the peptide. The latter is very difficult due to the multitude of metal-binding sites, but the fast koff facilitates removal. (iv) The high flexibility of the Cu-Aβ complex results in different conformations with different redox activity. Only some conformations are able to produce reactive oxygen species. (v) Other, more specific catalysis (like enzymes) is very unlikely for Cu/Zn-Aβ. (vi) The Cu/Zn exchange reactions with Aβ are faster than the aggregation process and can hence have a strong impact on this process. In conclusion, the coordination chemistry is fundamentally different for most of IDPs compared with the classical, structured metalloproteins or with (bio)-inorganic complexes. The dynamics is a key parameter to understand this interaction and its potential biological impact.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rae, T. D., Schmidt, P. J., Pufahl, R. A., Culotta, V. C., & V. O'Halloran, T. (1999) · Science · doi:10.1126/science.284.5415.805 · Cited by 1,629
Unusual biophysics of intrinsically disordered proteins
Uversky, V. N. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.12.008 · Cited by 566
Copper and iron disorders of the brain
Madsen, E., & Gitlin, J. D. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094232 · Cited by 557
Molecular structure of amyloid fibrils: insights from solid-state NMR
Tycko, R. (2006) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583506004173 · Cited by 527
Affinity gradients drive copper to cellular destinations
Banci, L., Bertini, I., Ciofi-Baffoni, S., Kozyreva, T., Zovo, K., & Palumaa, P. (2010) · Nature · doi:10.1038/nature09018 · Cited by 487
Crow, J. P., Sampson, J. B., Zhuang, Y., Thompson, J. A., & Beckman, J. S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69051936.x · Cited by 485
Copper, zinc and iron in neurodegenerative diseases (Alzheimer's, Parkinson's and prion diseases)
Kozlowski, H., Luczkowski, M., Remelli, M., & Valensin, D. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.013 · Cited by 437
A partially folded structure of amyloid-beta(1–40) in an aqueous environment
Vivekanandan, S., Brender, J. R., Lee, S. Y., & Ramamoorthy, A. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.133 · Cited by 432
Cytosolic zinc buffering and muffling: Their role in intracellular zinc homeostasis
Colvin, R. A., Holmes, W. R., Fontaine, C. P., & Maret, W. (2010) · Metallomics · doi:10.1039/b926662c · Cited by 428
Misfolded proteins in Alzheimer's disease and type II diabetes
DeToma, A. S., Salamekh, S., Ramamoorthy, A., & Lim, M. H. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15112f · Cited by 361
Role of Metal Ions in the Self-assembly of the Alzheimer’s Amyloid-β Peptide
Faller, P., Hureau, C., & Berthoumieu, O. (2013) · Inorganic Chemistry · doi:10.1021/ic4003059 · Cited by 353
Self-citationMetal complexing agents as therapies for Alzheimer’s disease
Bush, A. I. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00120-3 · Cited by 310
Faller, P. (2009) · ChemBioChem · doi:10.1002/cbic.200900321 · Cited by 285
Self-citationDual Nanomolar and Picomolar Zn(II) Binding Properties of Metallothionein
Krȩżel, A., & Maret, W. (2007) · Journal of the American Chemical Society · doi:10.1021/ja071979s · Cited by 283
Noy, D., Solomonov, I., Sinkevich, O., Arad, T., Kjaer, K., & Sagi, I. (2008) · Journal of the American Chemical Society · doi:10.1021/ja076282l · Cited by 215
Platinum-based inhibitors of amyloid-β as therapeutic agents for Alzheimer's disease
Barnham, K. J., Kenche, V. B., Ciccotosto, G. D., Smith, D. P., Tew, D. J., Liu, X., Perez, K., Cranston, G. A., Johanssen, T. J., Volitakis, I., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800712105 · Cited by 209
Parthasarathy, S., Long, F., Miller, Y., Xiao, Y., McElheny, D., Thurber, K., Ma, B., Nussinov, R., & Ishii, Y. (2011) · Journal of the American Chemical Society · doi:10.1021/ja1072178 · Cited by 199
Metal swap between Zn7-metallothionein-3 and amyloid-β–Cu protects against amyloid-β toxicity
Meloni, G., Sonois, V., Delaine, T., Guilloreau, L., Gillet, A., Teissié, J., Faller, P., & Vašák, M. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.89 · Cited by 190
Self-citationElevated labile Cu is associated with oxidative pathology in Alzheimer disease
James, S. A., Volitakis, I., Adlard, P. A., Duce, J. A., Masters, C. L., Cherny, R. A., & Bush, A. I. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.446 · Cited by 183
The Heterogeneous Nature of Cu2+Interactions with Alzheimer’s Amyloid-β Peptide
Drew, S. C., & Barnham, K. J. (2011) · Accounts of Chemical Research · doi:10.1021/ar200014u · Cited by 173
Cu(II) Affinity for the Alzheimer’s Peptide: Tyrosine Fluorescence Studies Revisited
Alies, B., Renaglia, E., Rózga, M., Bal, W., Faller, P., & Hureau, C. (2013) · Analytical Chemistry · doi:10.1021/ac302629u · Cited by 171
Self-citationHureau, C., & Dorlet, P. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.034 · Cited by 149
Self-citationHureau, C., Balland, V., Coppel, Y., Solari, P. L., Fonda, E., & Faller, P. (2009) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-009-0570-0 · Cited by 138
Self-citationCassagnes, L., Hervé, V., Nepveu, F., Hureau, C., Faller, P., & Collin, F. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201305372 · Cited by 134
Self-citationBioinorganic chemistry of copper coordination to alpha-synuclein: Relevance to Parkinson's disease
Binolfi, A., Quintanar, L., Bertoncini, C. W., Griesinger, C., & Fernández, C. O. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.05.004 · Cited by 134
Balland, V., Hureau, C., & Savéant, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011315107 · Cited by 126
Self-citationAbelein, A., Abrahams, J. P., Danielsson, J., Gräslund, A., Jarvet, J., Luo, J., Tiiman, A., & Wärmländer, S. K. T. S. (2014) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-014-1131-8 · Cited by 116
Talmard, C., Bouzan, A., & Faller, P. (2007) · Biochemistry · doi:10.1021/bi701355j · Cited by 111
Self-citationAliès, B., Badei, B., Faller, P., & Hureau, C. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201102746 · Cited by 103
Self-citationCopper(II) Coordination to Amyloid β: Murine versus Human Peptide
Eury, H., Bijani, C., Faller, P., & Hureau, C. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201005838 · Cited by 81
Self-citationValensin, D., Gabbiani, C., & Luigi Messori, A. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.04.010 · Cited by 77
Pedersen, J. T., Teilum, K., Heegaard, N. H. H., Østergaard, J., Adolph, H., & Hemmingsen, L. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006335 · Cited by 75
Pedersen, J. T., Hureau, C., Hemmingsen, L., Heegaard, N. H. H., Østergaard, J., Vašák, M., & Faller, P. (2012) · Biochemistry · doi:10.1021/bi201774z · Cited by 73
Self-citationJiang, D., Zhang, L., Grant, G. P. G., Dudzik, C. G., Chen, S., Patel, S., Hao, Y., Millhauser, G. L., & Zhou, F. (2012) · Biochemistry · doi:10.1021/bi301053h · Cited by 66
Local Structure and Global Patterning of Cu2+Binding in Fibrillar Amyloid-β [Aβ(1–40)] Protein
Gunderson, W. A., Hernández‐Guzmán, J., Karr, J. W., Sun, L., Szalai, V. A., & Warncke, K. (2012) · Journal of the American Chemical Society · doi:10.1021/ja306946q · Cited by 61
Penna, G. L., Hureau, C., Andreussi, O., & Faller, P. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp410046w · Cited by 57
Self-citationInterference of a new cyclometallated Pt compound with Cu binding to amyloid-β peptide
Sasaki, I., Bijani, C., Mallet‐Ladeira, S., Bourdon, V., Faller, P., & Hureau, C. (2012) · Dalton Transactions · doi:10.1039/c2dt12177h · Cited by 50
Self-citationAliès, B., Bijani, C., Sayen, S., Guillon, E., Faller, P., & Hureau, C. (2012) · Inorganic Chemistry · doi:10.1021/ic302097d · Cited by 45
Self-citationFurlan, S., Hureau, C., Faller, P., & Penna, G. L. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp308977s · Cited by 39
Self-citationZinc release of Zn7-metallothionein-3 induces fibrillar type amyloid-β aggregates
Durand, J., Meloni, G., Talmard, C., Vašák, M., & Faller, P. (2010) · Metallomics · doi:10.1039/c0mt00027b · Cited by 35
Self-citationDynamics of ZnII Binding as a Key Feature in the Formation of Amyloid Fibrils by Aβ11-28
Aliès, B., Solari, P., Hureau, C., & Faller, P. (2011) · Inorganic Chemistry · doi:10.1021/ic202247m · Cited by 25
Self-citationCopper–β-amyloid peptides exhibit neither monooxygenase nor superoxide dismutase activities
Ciregna, D., Monzani, E., Thiabaud, G., Pizzocaro, S., & Casella, L. (2013) · Chemical Communications · doi:10.1039/c3cc41297k · Cited by 16
Zhou, B., Hao, Y., Wang, C., Li, D., Liu, Y., & Zhou, F. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.09.001 · Cited by 14
Peck, K. L., Clewett, H. S., Schmitt, J. C., & Shearer, J. (2013) · Chemical Communications · doi:10.1039/c3cc40326b · Cited by 12
Cited by
Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Dominguez, L., Shea, J.-E., Dokholyan, N. V., De Simone, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 678
Self-citationSavelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 581
Biological metals and metal-targeting compounds in major neurodegenerative diseases
Barnham, K. J., & Bush, A. I. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00138a · Cited by 497
Rajasekhar, K., & Govindaraju, T. (2018) · RSC Advances · doi:10.1039/c8ra03620a · Cited by 150
Cheignon, C., Jones, M., Atrián-Blasco, E., Kieffer, I., Faller, P., Collin, F., & Hureau, C. (2017) · Chemical Science · doi:10.1039/c7sc00809k · Cited by 132
Self-citation
Metadata
- Authors
- Faller, P., Hureau, C., & La Penna, G.
- Venue
- Accounts of Chemical Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2014-05-29
- Volume
- 47
- Issue
- 8
- Pages
- 2252-2259
- ISSN
- 0001-4842 (ISSN-L)
- 1520-4898
- OpenAlex
- W2325973372
- Cited by
- 268
- References
- 44
- FWCI
- 13.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.